Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

[This corrects the article DOI: 10.3389/fonc.2020.605777.].

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 11; p. 670714
Main Authors Zhang, Meng-Xia, Wang, Li, Zeng, Lei, Tu, Zi-Wei
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 18.03.2021
Subjects
hypoxia-inducible factor 1-alpha
lipocalin 2
nasopharyngeal carcinoma
Oncology
radioresistance
recurrence
recurrence
lipocalin 2
nasopharyngeal carcinoma
hypoxia-inducible factor 1-alpha
radioresistance
Online AccessGet full text

Cover

More Information
Summary:[This corrects the article DOI: 10.3389/fonc.2020.605777.].
Bibliography:corrigendum
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
These authors have contributed equally to this work
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2021.670714